Manufactured Object
Congress Eyes Major PBM Reforms in Year-End Spending Bill
Pharmacy Benefit Managers (PBMs), PBM reforms, healthcare costs, year-end spending bill, Congress, bipartisan legislation, transparency, drug prices.
Bicycle Therapeutics Faces Stock Decline After Releasing Topline Data and Post-Hoc Analyses
Bicycle Therapeutics, stock decline, topline data, post-hoc analyses, cancer trials, zelenectide pevedotin, BT5528, metastatic urothelial cancer, Nectin-4 gene amplification.
Novo Nordisk Invests $1.2 Billion in Rare Disease Production Facility in Denmark, Creating 400 New Jobs
Novo Nordisk, rare disease production, Denmark, new facility, job creation, pharmaceutical industry
Novo Nordisk Invests $1.2 Billion in New Danish Production Facility for Rare Disease Therapies
Novo Nordisk, rare disease drugs, Denmark, production facility, investment, hemophilia, pharmaceutical manufacturing
EU Regulator Determines Mounjaro Effective for Sleep Apnea, No Separate Approval Required
Mounjaro, sleep apnea, EU regulator, European Medicines Agency (EMA), tirzepatide, weight loss, obesity
ICER Report Highlights $815 Million in Unjustified Drug Price Increases in 2023
ICER report, unsupported drug price hikes, 2023, pharmaceutical costs, healthcare spending
Walgreens Boots Alliance in Negotiations for Potential Sale to Private Equity Firm Sycamore Partners
Walgreens Boots Alliance, Sycamore Partners, private equity sale, retail industry, healthcare retail
2024 Biotech IPOs: Insights and Trends
Biotech IPOs, 2024 IPO trends, biopharma sector, initial public offerings, venture capital investment, healthcare innovation.
Supreme Court Declines to Review PhRMA’s Challenge to Arkansas’ 340B Contract Pharmacy Law
340B Program, Arkansas Act 1103, PhRMA, Supreme Court, Contract Pharmacies, Drug Pricing, Federal Preemption
Empowering Patients: The Key to Faster, More Impactful Research
Patient-centered care, Patient engagement, Personalized medicine, Clinical research, Healthcare outcomes, Patient empowerment